MktsMarkets

Genprex, Inc.
NASDAQ: GNPXKey statistics
GNPX News
Stories mentioning GNPX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||||
| Research & Development | 2,746 | 2,197 | 2,193 | 2,499 | 2,540 | 2,838 | 2,756 | 1,667 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (4,494) | (3,519) | (3,346) | (4,682) | (3,969) | (4,336) | (4,323) | (6,518) |
| Interest Income | 2.00 | 7.00 | 5.00 | 5.00 | 8.00 | 23.00 | ||
| Interest Expense | ||||||||
| Other Expense | (456.00) | 0.00 | ||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (4,462) | (3,790) | (3,799) | (4,675) | (3,965) | (4,330) | (4,316) | (6,496) |
| Earnings Per Share (Basic) | (0.64) | (4.06) | (5.00) | (0.17) | (12.98) | (54.12) | (61.65) | (3.00) |
| Earnings Per Share (Diluted) | ||||||||
| Weighted Average Shares Outstanding (Basic) | 6,952 | 933.00 | 761.00 | 27,594 | 305.00 | 80.00 | 70.00 | 2,162 |
| Weighted Average Shares Outstanding (Diluted) | ||||||||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About GNPX
Genprex, Inc. (NASDAQ: GNPX) is a stock listed on the Nasdaq Stock Market under the ticker symbol GNPX. It last traded at $2.07 (Nov 6, 2026, 4:00 PM ET), down 1.4% on the day. That gives Genprex a market capitalisation of $1.7M.
Over the past 52 weeks GNPX has traded between $1.71 and $138.60.
For the quarter ended Mar 31, 2026 it reported a net loss of $4.5M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$4.5M |
| Dec 31, 2025 | — | -$3.8M |
| Sep 30, 2025 | — | -$3.8M |
| Jun 30, 2025 | — | -$4.7M |
From Genprex’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…